查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737076

全球总体基因体学套件市场规模（按类型、应用、地区、范围和预测）

Global Metagenomics Kits Market Size By Type (Library Preparation Kits, Metagenomic Sequencing Kits), By Application (Drug Discovery, Clinical Diagnostics), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

总体基因体学套件的市场规模与预测

2024 年总体基因体学套件市场规模价值 78 亿美元，预计到 2032 年将达到 122 亿美元，2026 年至 2032 年的复合年增长率为 7.4%。

总体基因体学在各行各业的使用案例不断增多，政府和私营部门对大型测序计划的投资不断增加，慢性病病例的增加以及测序技术的突破，这些都是推动全球总体基因体学套件市场发展的关键因素。本研究报告对全球总体基因体学套件市场进行了全面评估，并深入分析了关键细分市场、趋势、市场驱动因素、竞争格局以及影响市场的关键因素。

定义全球总体基因体学套件市场

总体基因体学套件旨在利用半导体序列测定技术，快速、全面、广泛地研究混合微生物群落。总体基因体学套件可透过聚合酵素链锁反应扩增细菌高变异区。宏基因组学总体基因体学套件用于研究元基因组，宏基因组是直接从环境样本中提取的遗传物质。作为分析微生物族群与其宿主族群之间关联的基础资源，元基因组组样本是人类微生物组计划所必需的。

全球总体基因体学套件市场概况

总体基因体学是利用现代基因组学工具直接在自然环境中研究微生物群落的技术，无需分离特定物种或在实验室中培养，从而刺激了市场需求。总体基因体学具有监测污染物对生态系影响的潜力，并增强了污染环境的治理策略。元基因组分析已用于定义构成人类微生物组的微生物群落，有助于理解可能与人类健康相关的微生物组变化。由于此类应用的兴起，总体基因体学套件市场在预测期内预计将持续成长。癌症等慢性疾病的发生率不断上升，正推动全球基因的研究。

慢性病发病率的上升，以及研发治疗药物的研发活动的不断增加，推动了对总体基因体学套件的需求。此外，人们对个体化医疗的日益关注也有望推动市场发展。然而，在低度开发国家，大学的研发高度依赖外部资金。儘管世界各国政府和私人实体都在努力资助研究，但许多研究机构和学术机构在购买和使用昂贵的现代化设备和技术方面仍面临预算限制。因此，预计在预测期内，总体基因体学套件市场的扩张将受到阻碍。

目录

第 1 章全球宏总体基因体学套件市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章总体基因体学套件市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球宏总体基因体学套件市场（按类型）

  • 概述
  • 文库製备试剂套件
  • 元基因组定序套件
  • 样品萃取套件

第六章全球宏总体基因体学套件市场（依应用）

  • 概述
  • 药物研发
  • 临床诊断
  • 环境应用
  • 其他的

第七章全球宏总体基因体学套件市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第八章全球宏总体基因体学套件市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Perkin Elmer Inc.
  • Promega Connections
  • Thermo Fisher Scientific
  • Illumina, Inc.
  • Merck KGaA
  • QIAGEN NV
  • Novogene Co., Ltd.
  • Bio-Rad Laboratories Inc.
  • BGI Group
  • DNAstar, Inc.

第十章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十一章 附录

  • 相关调查
简介目录
Product Code: 50089

Metagenomics Kits Market Size And Forecast

Metagenomics Kits Market size was valued at USD 7.8 Billion in 2024 and is projected to reach USD 12.2 Billion by 2032, growing at a CAGR of 7.4 % during the forecast period 2026-2032.

The rising use of metagenomics across varied areas, increased government and private sector investment in large-scale sequencing projects, an increase in chronic illness cases, and breakthroughs in sequencing technology are some of the primary reasons driving the worldwide Metagenomics Kits Market. The Global Metagenomics Kits Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Metagenomics Kits Market Definition

The metagenomics kit is intended for a quick, thorough, and broad-reaching study of a mixed microbial community utilizing a semiconductor sequencing technique. The Metagenomics kit enables polymerase chain reaction amplification of bacteria's hypervariable areas. Metagenomics kits are used to investigate metagenomes, which are genetic materials extracted directly from environmental samples. As a fundamental resource for analyzing the link between microbial populations and the persons they inhabit, the human microbiome project requires a metagenomic sample.

Global Metagenomics Kits Market Overview

Metagenomics is the use of contemporary genomics tools to investigate communities of microbial organisms directly in their natural settings, eliminating the need for isolation and lab cultivation of specific species and therefore increasing market demand. Metagenomics has the potential to enhance tactics for monitoring the impact of contaminants on ecosystems and cleaning up polluted settings. The metagenomic analysis is being used to define the microbial communities that are a component of the human microbiome, which aids in understanding the changes in the human microbiome that can be linked to human health. The market for metagenomics kits may expand throughout the forecast period as a result of such applications. The increasing prevalence of chronic illnesses such as cancer has fueled global genetic research.

The rise in chronic illnesses, along with increased research and development activities to discover therapeutic medicines, has increased the demand for metagenomic kits. Furthermore, increased awareness of customized medicine is expected to push the market. However, in underdeveloped nations, university R&D is heavily reliant on outside financing. Despite ongoing attempts by governments and private organizations to offer funds for research across the world, numerous research and academic institutes confront budget limits when it comes to purchasing and utilizing modern and high-priced equipment and technology. As a result, the expansion of the Metagenomics Kits Market is projected to be hampered during the forecast period.

Global Metagenomics Kits Market: Segmentation Analysis

The Global Metagenomics Kits Market is segmented based on Type, Application, And Geography.

Metagenomics Kits Market, By Type

  • Library Preparation Kits
  • Metagenomic Sequencing Kits
  • Sample Extraction Kits

Based on Type, The market is segmented into Library Preparation Kits, Metagenomic Sequencing Kits, and Sample Extraction Kits. The Metagenomic Sequencing Kits segment category had the highest market share of the Metagenomics Kits Market and is predicted to develop at a substantial rate due to advances in DNA sequencing and an increase in the expansion of metagenomics applications driving the growth of the Global Metagenomics Kits Market.

Metagenomics Kits Market, By Application

  • Drug Discovery
  • Clinical Diagnostics
  • Environmental Applications
  • Others

Based on Application, The market is segmented into Drug Discovery, Clinical Diagnostics, Environmental Applications, and Others. In 2021, the Drug Discovery category held the greatest proportion of the Metagenomics Kits Market. This segment's substantial share may be ascribed to increased research efforts for innovative medication discovery and rising drug development collaborations between market participants, academic institutions, and pharmaceutical corporations.

Metagenomics Kits Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, The Global Metagenomics Kits Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In 2021, North America held the greatest proportion of the Metagenomics Kits Market. The rising uses of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the expansion of the North American Metagenomics Kits Market.

Key Players

The "Global Metagenomics Kits Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Perkin Elmer Inc., Promega Connections, Thermo Fisher Scientific, Illumina, Inc., Merck KGaA, QIAGEN N.V., Novogene Co., Ltd., Bio-Rad Laboratories Inc., BGI Group, DNAstar, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In January 2021, Illumina (US) introduced Illumina Connected Analytics (ICA), a new and integrated bioinformatics tool for managing, analyzing, and exploring massive amounts of multi-omics data.
  • In December 2020, Using the metagenomics technique, Beijing Tongren Hospital initiated a clinical study to investigate the etiology and epidemiology of central nervous system illness (Meningitis Encephalitis) throughout China.
  • In August 2020, Massachusetts General Hospital launched a research experiment called GEMMA-Genome Environment Microbiome and Metabolome in Autism to find possible biomarkers predictive of autism development in the blood, feces, urine, and saliva utilizing microbiome/metagenomic/metatranscriptomic analyses.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL METAGENOMICS KITS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL METAGENOMICS KITS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL METAGENOMICS KITS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Library Preparation Kits
  • 5.3 Metagenomic Sequencing Kits
  • 5.4 Sample Extraction Kits

6 GLOBAL METAGENOMICS KITS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Drug Discovery
  • 6.3 Clinical Diagnostics
  • 6.4 Environmental Applications
  • 6.5 Others

7 GLOBAL METAGENOMICS KITS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL METAGENOMICS KITS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Perkin Elmer Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Promega Connections
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Thermo Fisher Scientific
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Illumina, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Merck KGaA
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 QIAGEN N.V.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Novogene Co., Ltd.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Bio-Rad Laboratories Inc.
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 BGI Group
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 DNAstar, Inc.
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research